BiotechTube
OspreyBio

OspreyBio

San Diego, United States· Est.
ospreybio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

OspreyBio is a private, pre-revenue platform and services company founded in 2018 and based in San Diego. It has developed the Bird of Prey platform, a standardized and modular DNA assembly system designed to overcome the slow, costly, and complex bottlenecks of traditional vector construction. By offering a library of pre-made genetic modules and custom construction services, OspreyBio enables researchers to rapidly iterate on multi-gene vector designs for complex biological applications in oncology, immunology, and beyond. The company targets a growing market need for efficient genetic tooling across the R&D continuum.

OncologyImmunology

Technology Platform

Bird of Prey Platform: A standardized, modular DNA assembly system using a library of pre-made regulatory elements, ORFs, and reporters to enable rapid, iterative construction of complex, polygenic vectors for research and therapy development.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The rapid growth of cell and gene therapies, which require complex multi-gene vectors, creates a strong demand for efficient, standardized construction tools.
Additionally, the broader push for speed and reproducibility in biological R&D across academia and industry presents a large, addressable market for a platform that can significantly reduce design iteration time.

Risk Factors

The company faces competition from established gene synthesis providers and must convince researchers to adopt its specific standardized system over traditional methods.
Its service-based model may face scalability challenges, and its success is heavily dependent on the continuous expansion and performance of its proprietary module library.

Competitive Landscape

OspreyBio competes with large gene synthesis and cloning service providers (e.g., GenScript, Twist Bioscience, Integrated DNA Technologies) and other synthetic biology startups offering modular DNA assembly toolkits. Its differentiation lies in its specific focus on standardized, large-payload, polygenic vector construction as a service, targeting complex therapeutic and research applications directly.

More companies in United States →